Further analysis in gastric cancer revealed the underlying mechanism, whereby IQGAP2 interacted with SHIP2, and increased its phosphatase activity, deactivating Akt and decreasing EMT [38]. The gene discussed is IQGAP2; the disease is gastric cancer.